Cite
Free PSA Ratio as a Predictor of Adverse Outcomes after Curative-Intent External Beam Radiation Therapy for Prostate Cancer: A Novel Application of an "Old" Biomarker.
MLA
Goldberg, H., et al. “Free PSA Ratio as a Predictor of Adverse Outcomes after Curative-Intent External Beam Radiation Therapy for Prostate Cancer: A Novel Application of an ‘Old’ Biomarker.” International Journal of Radiation Oncology, Biology, Physics, vol. 102, Nov. 2018, p. e112. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2018.07.307.
APA
Goldberg, H., Glicksman, R., Fleshner, N. E., Woon, D. T. S., Klaassen, Z., Chandrasekar, T., Caceres, J. O. H., Salgado, N. S., Qu, M. X., Moraes, F. Y., Kulkarni, G. S., Hamilton, R. J., Chung, P., Catton, C. N., Finelli, A., & Berlin, A. (2018). Free PSA Ratio as a Predictor of Adverse Outcomes after Curative-Intent External Beam Radiation Therapy for Prostate Cancer: A Novel Application of an “Old” Biomarker. International Journal of Radiation Oncology, Biology, Physics, 102, e112. https://doi.org/10.1016/j.ijrobp.2018.07.307
Chicago
Goldberg, H., R. Glicksman, N.E. Fleshner, D.T.S. Woon, Z. Klaassen, T. Chandrasekar, J.O.H. Caceres, et al. 2018. “Free PSA Ratio as a Predictor of Adverse Outcomes after Curative-Intent External Beam Radiation Therapy for Prostate Cancer: A Novel Application of an ‘Old’ Biomarker.” International Journal of Radiation Oncology, Biology, Physics 102 (November): e112. doi:10.1016/j.ijrobp.2018.07.307.